Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents
DOI:
https://doi.org/10.15605/jafes.040.02.06Keywords:
enteral nutrition, blood glucose, steroid-induced hyperglycemia, acute medical care, surgical stressAbstract
Objective. To verify whether reducing the energy ratio of carbohydrates and increasing the ratio of fats contributes to suppressing blood glucose elevation not only under normal conditions but also under the effects of glucocorticoids.
Methodology. Three test enteral nutrition (EN) solutions, differing in energy ratios and used in actual clinical settings, were given to rats: HINEX E-Gel (ST) with 20% fat and 64% carbohydrate content; HINEX E-Gel LC (LC) with 34% fat and 50% carbohydrate content; and HINEX Renute (RN) with 50% fat and 26% carbohydrate content. The time-course data of plasma glucose, triglyceride, and insulin levels after a single oral administration of the test EN solution were obtained in normal rats (Experiment 1) and in hyperglycemia model rats treated with dexamethasone (Experiment 2).
Results. In both normal and dexamethasone-induced hyperglycemic rats, plasma glucose levels were lower in the groups given RN than in the groups given ST. The differences in EN solutions did not significantly affect plasma triglyceride and insulin levels in either rat model.
Conclusion. The study suggests that an EN solution high in fat and low in carbohydrate suppresses the post-administration increase of blood glucose levels, even in a state of steroid-induced hyperglycemia with insulin resistance.
Downloads
References
1. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251-76. https://pubmed.ncbi.nlm.nih.gov/23164767 https://doi.org/10.1097/CCM.0b013e3182653269
2. Burslem R, Rigassio Radler D, Parker A, Zelig R. Low-carbohydrate, high-fat enteral formulas for managing glycemic control in patients who are critically ill: A review of the evidence. Nutr Clin Pract. 2022;37(1):68-80. https://pubmed.ncbi.nlm.nih.gov/33734480 https://doi.org/10.1002/ncp.10652
3. Nygren J. The metabolic effects of fasting and surgery. Best Pract Res Clin Anaesthesiol. 2006;20(3):429-38. https://pubmed.ncbi.nlm.nih.gov/17080694 https://doi.org/10.1016/j.bpa.2006.02.004
4. Mori Y, Kitamura T, Kawamura G, et al. Effects of preoperative and intraoperative glucose administration on glucose use and fat catabolism during laparotomy under sevoflurane anesthesia in fasted rats. J Physiol Sci. 2015;65(6):523-30. https://pubmed.ncbi.nlm.nih.gov/26280893 https://pmc.ncbi.nlm.nih.gov/articles/PMC10717368 https://doi.org/10.1007/s12576-015-0390-7
5. Mizock BA. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med. 1995;98(1):75-84. https://pubmed.ncbi.nlm.nih.gov/7825623 https://doi.org/10.1016/S0002-9343(99)80083-7
6. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001;58(8):1209-12. https://pubmed.ncbi.nlm.nih.gov/23470218 https://pmc.ncbi.nlm.nih.gov/articles/PMC3672537 https://doi.org/10.1186/cc12514
7. Marik PE, Bellomo R. Stress hyperglycemia: An essential survival response! Crit Care. 2013;17(2):305. https://pubmed.ncbi.nlm.nih.gov/23470218 https://pmc.ncbi.nlm.nih.gov/articles/PMC3672537 https://doi.org/10.1186/cc12514
8. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55-89. https://pubmed.ncbi.nlm.nih.gov/10696570 https://doi.org/10.1210/edrv.21.1.0389
9. Berrone E, Beltramo E, Solimine C, Ape AU, Porta M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem. 2006;281(14):9307-13. https://pubmed.ncbi.nlm.nih.gov/16452468 https://doi.org/10.1074/jbc.M600418200
10. Bach AC, Babayan VK. Medium-chain triglycerides: An update. Am J Clin Nutr. 1982 36(5):950-62. https://pubmed.ncbi.nlm.nih.gov/6814231 https://doi.org/10.1093/ajcn/36.5.950
11. Papamandjaris AA, MacDougall DE, Jones PJ. Medium chain fatty acid metabolism and energy expenditure: Obesity treatment implications. Life Sci. 1998;62(14):1203-15. https://pubmed.ncbi.nlm.nih.gov/9570335 https://doi.org/10.1016/s0024-3205(97)01143-0
12. Miyagawa Y, Mori T, Goto K, et al. Intake of medium-chain fatty acids induces myocardial oxidative stress and atrophy. Lipids Health Dis. 2018;17(1):258. https://pubmed.ncbi.nlm.nih.gov/30447697 https://pmc.ncbi.nlm.nih.gov/articles/PMC6240279 https://doi.org/10.1186/s12944-018-0908-0
13. Saggerson ED, Carpenter CA. Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart. FEBS Lett. 1981;129(2):229-32. https://pubmed.ncbi.nlm.nih.gov/7286216 https://doi.org/10.1016/0014-5793(81)80171-8
14. Jadhav HB, Annapure US. Triglycerides of medium‑chain fatty acids: A concise review. J Food Sci Technol. 2023;60:2143-52. https://pubmed.ncbi.nlm.nih.gov/35761969 https://pmc.ncbi.nlm.nih.gov/articles/PMC9217113 https://doi.org/10.1007/s13197-022-05499-w
15. Schönfeld P, Wojtczak L. Short- and medium-chain fatty acids in energy metabolism: The cellular perspective. J Lipid Res. 2016;57(6):943-54. https://pubmed.ncbi.nlm.nih.gov/27080715 https://pmc.ncbi.nlm.nih.gov/articles/PMC4878196 https://doi.org/10.1194/jlr.R067629
16. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2006; 1863(10): 2422-35. https://pubmed.ncbi.nlm.nih.gov/26828774 https://pmc.ncbi.nlm.nih.gov/articles/PMC4967041 https://doi.org/10.1016/j.bbamcr.2016.01.023
17. Genito CJ, Eckshtain-Levi M, Piedra-Quintero ZL, et al. Dexamethasone and fumaric acid ester conjugate synergistically inhibits inflammation and NF-κB in macrophages. Bioconjug Chem. 2021;32(8):1629-40. https://pubmed.ncbi.nlm.nih.gov/34165285 https://pmc.ncbi.nlm.nih.gov/articles/PMC10372493 https://doi.org/10.1021/acs.bioconjchem.1c00200
18. Cui A, Fan H, Zhang Y, et al. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. J Clin Invest. 2019;129(6):2266-78. https://pubmed.ncbi.nlm.nih.gov/31033478 https://pmc.ncbi.nlm.nih.gov/articles/PMC6546458 https://doi.org/10.1172/JCI66062
19. Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: Precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017;18(3):159-74. https://pubmed.ncbi.nlm.nih.gov/28053348 https://pmc.ncbi.nlm.nih.gov/articles/PMC6257982 https://doi.org/10.1038/nrm.2016.152
20. Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: Focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. 2014;43(1):75-102. https://pubmed.ncbi.nlm.nih.gov/24582093 https://pmc.ncbi.nlm.nih.gov/articles/PMC3942672 https://doi.org/10.1016/j.ecl.2013.10.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hiroaki Kato, Sho Miyatake, Ippei Yamaoka
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
